Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$8.71 - $10.72 $150,099 - $184,737
-17,233 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$9.2 - $23.86 $2,336 - $6,060
254 Added 1.5%
17,233 $170,000
Q4 2020

Feb 05, 2021

BUY
$13.47 - $24.89 $8,149 - $15,058
605 Added 3.69%
16,979 $392,000
Q3 2020

Nov 03, 2020

BUY
$12.89 - $15.89 $211,060 - $260,182
16,374 New
16,374 $231,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.7B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Pitcairn CO Portfolio

Follow Pitcairn CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.